Mutalik S - Search Results

1

Epidrugs in the clinical management of atherosclerosis: Mechanisms, challenges and promises.

Panduga S, Vasishta S, Subramani R, Vincent S, Mutalik S, Joshi MB. Panduga S, et al. Among authors: mutalik s. Eur J Pharmacol. 2024 Oct 5;980:176827. doi: 10.1016/j.ejphar.2024.176827. Epub 2024 Jul 20. Eur J Pharmacol. 2024. PMID: 39038635 Free article. Review.

2

Neuroprotection: A versatile approach to combat glaucoma.

Naik S, Pandey A, Lewis SA, Rao BSS, Mutalik S. Naik S, et al. Among authors: mutalik s. Eur J Pharmacol. 2020 Aug 15;881:173208. doi: 10.1016/j.ejphar.2020.173208. Epub 2020 May 25. Eur J Pharmacol. 2020. PMID: 32464192 Review.

3

Stimuli-responsive and cellular targeted nanoplatforms for multimodal therapy of skin cancer.

Padya BS, Pandey A, Pisay M, Koteshwara KB, Chandrashekhar Hariharapura R, Bhat KU, Biswas S, Mutalik S. Padya BS, et al. Among authors: mutalik s. Eur J Pharmacol. 2021 Jan 5;890:173633. doi: 10.1016/j.ejphar.2020.173633. Epub 2020 Oct 10. Eur J Pharmacol. 2021. PMID: 33049302 Review.

4

Mannosylated-Chitosan-Coated Andrographolide Nanoliposomes for the Treatment of Hepatitis: In Vitro and In Vivo Evaluations.

Metkar SP, Fernandes G, Nikam AN, Soman S, Birangal S, Seetharam RN, Joshi MB, Mutalik S. Metkar SP, et al. Among authors: mutalik s. Membranes (Basel). 2023 Feb 3;13(2):193. doi: 10.3390/membranes13020193. Membranes (Basel). 2023. PMID: 36837696 Free PMC article.

5

Enhanced effect of geldanamycin nanocomposite against breast cancer cells growing in vitro and as xenograft with vanquished normal cell toxicity.

Prabhu S, Ananthanarayanan P, Aziz SK, Rai S, Mutalik S, Sadashiva SR. Prabhu S, et al. Among authors: mutalik s. Toxicol Appl Pharmacol. 2017 Apr 1;320:60-72. doi: 10.1016/j.taap.2017.02.012. Epub 2017 Feb 16. Toxicol Appl Pharmacol. 2017. PMID: 28213093

6

Exposure to first line anti-tuberculosis drugs in prepubertal age reduces the quality and functional competence of spermatozoa and oocytes in Swiss albino mice.

Rao A, Nayak G, Kumari S, Kalthur SG, Mutalik SP, Mutalik S, Adiga SK, Kalthur G. Rao A, et al. Among authors: mutalik sp, mutalik s. Environ Toxicol Pharmacol. 2020 Jan;73:103292. doi: 10.1016/j.etap.2019.103292. Epub 2019 Nov 6. Environ Toxicol Pharmacol. 2020. PMID: 31765964

7

Curcumin nanocrystals attenuate cyclophosphamide-induced testicular toxicity in mice.

Poojary KK, Nayak G, Vasani A, Kumari S, Dcunha R, Kunhiraman JP, Gopalan D, Rao RR, Mutalik S, Kalthur SG, Murari MS, Raghu SV, Adiga SK, Kalthur G. Poojary KK, et al. Among authors: mutalik s. Toxicol Appl Pharmacol. 2021 Dec 15;433:115772. doi: 10.1016/j.taap.2021.115772. Epub 2021 Oct 27. Toxicol Appl Pharmacol. 2021. PMID: 34715073

8

Biodegradable microspheres of curcumin for treatment of inflammation.

Kumar V, Lewis SA, Mutalik S, Shenoy DB, Venkatesh, Udupa N. Kumar V, et al. Among authors: mutalik s. Indian J Physiol Pharmacol. 2002 Apr;46(2):209-17. Indian J Physiol Pharmacol. 2002. PMID: 12500496

9

Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases.

Anthony DP, Hegde M, Shetty SS, Rafic T, Mutalik S, Rao BSS. Anthony DP, et al. Among authors: mutalik s. Life Sci. 2021 Jun 1;274:119326. doi: 10.1016/j.lfs.2021.119326. Epub 2021 Mar 9. Life Sci. 2021. PMID: 33711385 Review.

10

Pharmacological evaluation of membrane-moderated transdermal system of glipizide.

Mutalik S, Udupa N. Mutalik S, et al. Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):17-26. doi: 10.1111/j.1440-1681.2006.04318.x. Clin Exp Pharmacol Physiol. 2006. PMID: 16445694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters